Acute Lymphoblastic Leukemia
Pediatric protocols yield better outcomes for young-adult ALL patients
Published in Cancer Weekly, September 13th, 2005
"Young-adult patients with acute lymphoblastic leukemia represent a unique epidemiologic subgroup in that therapy may be provided by either adult or pediatric oncologists. There seem to be no differences in presenting clinical features, immunophenotypic characteristics, or cytogenetic abnormalities for young-adult ALL patients treated on pediatric or adult protocols with the exception of median age (16 - pediatric trials versus 19 - adult trials)," scientists in the United States reported.
"There is no evidence to suggest that age within the 16-21...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-09-13)
More Articles from Cancer Weekly
- Carcinogenesis
Storage practices impacted acrylamide formation during potato frying - Neurofibroma
Soft tissue perineurioma clinicopathologically analyzed - Ovarian Cancer
Patients unlikely to benefit from further chemotherapy identified - Suicide
Prostate cancer deemed risk factor for late-life suicide - Adenocarcinoma
Outcome of surgical treatment for early esophageal adenocarcinoma revealed - Adenomas
Adenoma with gastric differentiation reported - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
